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Optimal Duration of Intrapartum Antibiotic Prophylaxis for Group B Streptococcus
And Effects on Practice Patterns. Emma L. Barber, BS; Edmund F. Funai, MD;
Michael B. Bracken, PhD, MPH; Guomao Zhao, BS; Irina A. Buhimschi, MD; and
Jessica L. Illuzzi, MD. Department of Obstetrics, Gynecology, and Reproductive
Sciences, Yale University School of Medicine, New Haven, Connecticut.
The 2002 CDC guidelines recommend a minimum of four hours of intrapartum peni-
cillin G prophylaxis to assure a neonate is adequately prophylaxed against group B strep-
tococcus (GBS). We examined the validity of this duration through the relationship between
duration of prophylaxis and fetal serum penicillin G levels among fetuses exposed to less
than four hours of prophylaxis compared to longer durations. We also investigated if cli-
nicians were altering management to achieve four hours of prophylaxis. Ninety-eight la-
boring GBS positive women carrying singleton gestations >37 weeks received penicillin G
according to the CDC protocol. Umbilical cord blood samples were collected at delivery
and penicillin G levels measured by high-performance liquid chromatography. Intra and
inter-assay coefficient of variation were <3 percent. Seventy of 96 eligible clinicians (72.9
percent) completed our survey. Fetuses exposed to less than four hours prophylaxis had
higher penicillin G levels than those exposed to greater than four hours (p = 0.003). In mul-
tivariable linear regression analysis, fetal penicillin G levels were determined by time of ex-
posure, time since last dose, dosage, and number of doses, but not maternal BMI. Penicillin
G levels increased linearly until one hour (R2 = .40) and then decreased rapidly according
to a power-decay model (R2 = .67). All sub-groups analyzed were above the minimum in-
hibitory concentration (MIC) for GBS (0.1ʼg/mL)(p < 0.002). Individual samples were
10-179 fold above the MIC. In our survey, only 22.9 percent of clinicians reported not al-
tering their management of labor in GBS positive pregnancies that achieved less than four
hours of prophylaxis. These alterations included “laboring down” or delaying pushing;
turning off or decreasing an oxytocin infusion; or delaying or avoiding artificial rupture of
membranes. Short durations of prophylaxis achieved levels significantly above the MIC,
suggesting a benefit even in precipitous labors. The designation of infants exposed to less
than four hours of prophylaxis as particularly at risk for GBS sepsis may be pharmacoki-
netically inaccurate. However, clinicians report delaying labor to achieve four hours. The
2002 CDC guidelines are being interpreted differently in the clinical setting than the authors
may have intended. The effects and consequences of this interpretation are unknown.
Impairment of Synaptic Plasticity by Amyloid-ʲ Oligomers and Memory Dysfunction
in Transgenic Alzheimer's Mice Requires Cellular Prion Protein.David Adam Gimbel.
Yale University School of Medicine, New Haven, Connecticut.
The accumulation of insoluble plaque containing 40-42 amino acid amyloid beta (Aʲ)
peptide is a well-understood hallmark of Alzheimer’s disease (AD). The amount of insol-
uble plaque does not correlate well with the degree of dementia. Rather, it appears that pre-
fibrillar,  soluble  oligomers  of Aʲ  are  the  key  intermediates  in AD-related  synaptic
dysfunction. At nanomolar concentration, Aʲ oligomers block hippocampal long-term po-
tentiation (LTP), cause neuronal dendritic spine retraction, and cause acute memory im-
pairment in a naїve animal. These acute impairments in synaptic structure and function
imply the existence of a high-affinity functional receptor for Aʲ oligomers. We used ex-Thesis award recipients 142
pression cloning to identify cellular prion protein (PrPC) as binding partner for oligomeric
Aʲ. These oligomers bind with nanomolar affinity to PrPC and the interaction is specific for
the oligomeric form. PrPf' is required for the suppression of synaptic plasticity in hip-
pocampal slices by oligomeric Aʲ peptide. We crossed familial AD transgenes encoding
APPswe and PSen1ʔE9 into PrP-/- mice to examine the necessity of PrPC for AD pheno-
types. Absence of PrPC left APP expression, Aʲ levels, and astrogliosis unchanged. How-
ever, PrPC deletion rescued axonal degeneration, loss of synaptic markers, and early death
in AD transgenic mice. Mice lacking PrPC show no transgene associated impairment of
learning and memory. Thus, deletion of PrPC expression dissociates Aʲ accumulation from
behavioral impairment in AD transgenic mice. This solidifies the role of PrPC as a high
affinity, functional receptor for Aʲ oligomers and proves its necessity in the Aʲ associated
pathological cascade of Alzheimer’s disease.
Routine Opt-Out HIV Testing in Jails: Findings from Two Prospective Controlled
Trials. Ravi Kavasery. Yale University School of Medicine, New Haven, Connecticut.
Background: Tens of millions of Americans enter jails annually. The Centers for Dis-
ease Control and Prevention now recommends routine HIV testing in prisons and jails. The
logistics for performing routine HIV testing within jails, however, remains controversial. Spe-
cificAims: 1) To simulate and explore the feasibility of future implementation of a routine opt-
out HIV testing protocol using rapid testing methods in the often-chaotic jail setting. 2) To
evaluate the optimal time to perform routine HIV testing among inmates who are competent
to consent to testing, in a manner that not only maximizes public health but also attends to the
safety and health status of individual inmates. Methods: Two prospective, controlled trials of
routine opt-out HIV testing were conducted among 323 newly incarcerated female inmates in
Connecticut’s only women’s jail (during August and September 2007) and 298 newly incar-
cerated male inmates in an urban men’s jail in New Haven, Connecticut (during March and
April 2008). Sequential entrants at both facilities were assigned to be offered routine opt-out
HIV testing at one of three points after incarceration: immediate (same day), early (next day),
or delayed (seven days). The primary outcome was the proportion of individuals in each group
consenting to testing. Results: In the women’s trial, routine opt-out HIV testing was signifi-
cantly highest (73 percent) among the early testing group compared to 55 percent for imme-
diate and 50 percent for seven days post-entry groups. Other factors significantly (p = 0.01)
associated with being HIV tested were younger age and low likelihood of early release from
jail based on bond value or type of charge for which women were arrested. In the men’s trial,
routine opt-out HIV testing was significantly higher for the early (53 percent: AOR = 2.6; 95
percent CI = 1.5 to 4.7) and immediate (45 percent: AOR = 2.3; 95 percent CI = 1.3 to 4.0)
testing groups compared to the delayed (33 percent) testing group. The immediate and early
testing groups, however, did not significantly differ (p = 0.67). In multivariate analyses, fac-
tors significantly associated with routine opt-out HIV testing were assignment to the “early”
testing group (p = 0.0003) and low (bond >=$5,000, immigration or federal charges or pre-
sentencing >30 days) likelihood of early release (p = 0.04). Two male subjects received pre-
liminary positive results, and one was subsequently confirmed HIV seropositive. Conclusions:
In both correctional facilities, routine opt-out HIV testing in a jail setting was feasible, with
highest rates of testing if performed within 24 hours of incarceration. Lower testing rates were
seen with immediate testing, where there is a high prevalence of inability or unwillingness to
test, and with delayed testing, where attrition from jail increases with each passing day.
Evaluation  of  BD  GeneOhm  CDiff  PCR Assay  for  Diagnosis  of  Toxigenic
Clostridium difficile Infection. Elizabeth Kvach. Yale University School of Medicine,
New Haven, Connecticut.
Clostridium difficile is the most common infectious cause of nosocomial diarrhea, af-
fecting thousands of patients annually and exacting enormous costs on the U.S. healthcareThesis award recipients 143
system. Early diagnosis is critical to prevent transmission and reduce morbidity and mortal-
ity, yet sensitive and specific diagnostic tests with a quick turnaround time are lacking. The
objective of this study was to determine if a new commercially available real time polymerase
chain reaction (PCR) test would prove more rapid, sensitive, and specific than standard meth-
ods for the diagnosis of C. difficile infection (CDI). BD GeneOhm™ Cdiff assay, a real-time
PCR assay for detection of C. difficile toxin B (tcdB) gene, was compared with Tox A/B II™
ELISA and a two-step algorithm that includes C. Diff Chek-60™ Glutamate Dehydrogenase
(GDH)-antigen assay followed by cytotoxin neutralization. Four hundred liquid or semisolid
stools submitted for diagnostic C. difficile testing were selected; 200 were GDH antigen-pos-
itive and 200 were GDH antigen-negative. All samples were tested by the C. Diff Chek-60™
GDH antigen, cytotoxin neutralization, Toxin A/B II™ ELISA, and BD GeneOhm™ Cdiff
assay. Discrepant specimens were tested by toxigenic culture as an independent gold stan-
dard. Chart review was performed on patients with discrepant specimens. As BD GeneOhm™
Cdiff assay was not FDA-cleared at the time of study, PCR results were not clinically re-
ported. Of 200 GDH-positive samples, 71 were positive by Tox A/B II, 88 were positive by
the two-step method, 93 were positive by PCR, and 96 were positive by GDH-antigen only.
Of 200 GDH-negative samples, three were positive by PCR only. Toxigenic culture was per-
formed on 41 samples with discrepant results, and 39 were culture-positive. After culture res-
olution of discrepants, Tox A/B II detected 70 (66.7 percent), the two-step method detected 87
(82.9 percent), and PCR detected 96 (91.4 percent) of 105 true positives. The BD Gene-
Ohm™ Cdiff assay was more sensitive in detecting toxigenic C. difficile than Tox A/B II (p
< 0.0001); however, the difference between PCR and the two-step method was not significant
(p = 0.1237). The BD GeneOhm™ Cdiff assay took a similar amount of time to perform as
the Tox A/B II and was more rapid than the two-step method. Chart review revealed that 18
patients with cytotoxin-negative, PCR-positive discrepant samples were given one to two days
of therapy (n = 8) or no treatment at all (n = 10). Yet symptoms resolved, and no further C.
difficile testing was requested for 13 of 18 patients for six to eight months after hospital dis-
charge. Only one patient had a subsequent cytotoxin positive stool submitted 22 days after the
study sample was tested. Enhanced sensitivity and rapid turnaround time make the BD Ge-
neOhm™ Cdiff assay an important advance in the diagnosis of toxigenic C. difficileinfection.
The BD GeneOhm™ Cdiff assay is significantly more sensitive than a commonly used ELISA
toxin assay and has a sensitivity and specificity comparable to the two-step method. Its turn-
around time is similar to ELISA toxin assays and more rapid than the two-step method. Dis-
advantages to implementation of BD GeneOhm™ Cdiff assay include increased cost and
potential treatment of asymptomatic carriers and mild, self-resolving disease.
Induction of Pluripotency in Human Keratinocytes Through mRNA Transfection.
Robert D. Leone, Peter M. Rabinovich, Eugenie Cheng, Efim Golub, and Sherman M.
Weissman. Department of Genetics, Yale University School of Medicine, New Haven,
Connecticut.
Induced pluripotent stem (iPS) cells are epigenetically reprogrammed somatic cells
that exhibit developmental and proliferative characteristics of embryonic stem (ES) cells.
Other than alterations made during the reprogramming process, iPS cells are genotypically
identical to donor tissue, giving them significant potential in regenerative medicine, basic
biology of genetic disease, and drug development. Currently, iPS cell derivation largely re-
lies on the introduction of reprogramming factors (e.g., OCT4, SOX2, KLF4, c-MYC) di-
rectly into cellular genomes, leaving cells vulnerable to insertional mutagenesis and
persistent expression of oncogenic transcription factors. This severely limits their use in
clinical and research settings. Here we describe the reprogramming of human keratinocytesThesis award recipients 144
through the introduction of exogenous mRNA transcripts. mRNA presence within cells is
transient and unlikely to have permanent effects on the cellular genome, thus avoiding the
pitfalls of current methods of iPS cell generation. Several benchmarks have been achieved
toward this end, including: 1) successful expression in human cells of reprogramming fac-
tor proteins through the introduction of exogenous mRNA transcripts; 2) phenotypic trans-
formation of human keratinocytes toward ES cell morphology by transfection with mRNA
reprogramming factors; and 3) alkaline phosphatase activity (a well-described early marker
of pluripotency) in a small proportion of transformed cells. These results imply that mRNA
transfection may be a viable method for reprogramming somatic cells toward pluripotency.
Renal Ultrasound in the Evaluation of Acute Kidney Injury: Developing a Risk
Stratification Framework. Adam Licursea, Michael Kimb, Howard Formanc, Richard
Formica
d, Chirag Parikh
d, Danil Makarove, James Dziuraf, and Cary Grossg.aYale 
University School of Medicine;  bYale College;  cDepartment of Radiology, Yale 
University School of Medicine;  dSection of Nephrology, Department of Internal 
Medicine, Yale University School of Medicine;  eRobert Wood Johnson Clinical 
Scholars Program, Yale University School of Medicine; fYale Center for Clinical 
Investigation, Yale University School of Medicine; gSection of General Medicine, Yale
University School of Medicine, New Haven, Connecticut.
Background: In adult in-patients with acute kidney injury (AKI), clinicians routinely
order a renal ultrasound (RUS). It is unclear how often this test provides clinically useful
information. Specific Aims: We aimed to develop a simple decision rule that will identify
those patients with AKI who are at low risk of hydronephrosis (HN) on RUS or HN re-
quiring an intervention (HNRI; defined as nephrostomy tube or stent placement). Using
this classification scheme, we also aimed to evaluate the effectiveness of RUS evaluation
in each group, in terms of number needed to screen (NNS). Methods: We conducted a cross-
sectional study, divided into derivation and validation samples. Our sample consisted of
997 U.S. adult in-patients who were admitted to Yale-New Haven Hospital (YNHH) from
January 1, 2005 to May 1, 2009, diagnosed with AKI, and received diagnostic RUS in the
evaluation of their elevated Creatinine. Pregnant women, renal transplant recipients, and
patients with recently diagnosed HN were excluded. Demographic and clinical character-
istics were abstracted from the medical records, including pre-existing comorbidities, in-
patient  course  (e.g.,  use  of  pressors)  and  exposures  (e.g.,  contrast  or  nephrotoxic
medications). A multivariable logistic regression model was used to create risk strata for HN
and HNRI; a separate sample was used for validation. We assessed the presence of inci-
dental findings on RUS for each stratum (i.e., other clinically useful findings other than
presence of HN). In the validation sample, patients were classified according to their risk
of HN; this system was assessed in terms of its sensitivity, specificity, negative predictive
value (NPV), NNS, and cost of RUS evaluation per positive study. Results: In the deriva-
tion sample of 200 patients, seven factors were found to be associated with HN: history of
HN, recurrent urinary tract infections, diagnosis consistent with obstruction, non-black race;
and absence of/exposure to nephrotoxic medications, congestive heart failure, or pre-renal
status prior to AKI. Patients were assigned to the low risk group when 0-2 risk factors were
present, medium risk group when three factors were present, and high risk group when four
or more factors were present or when there was a documented history of HN. Among 797
patients in the validation sample (mean age of 65.6 years), 10.6 percent had HN and 3.3 per-
cent had HNRI. Of the 223 patients assigned to the low risk group, seven (3.1 percent) had
HN and one (0.4 percent) had HNRI (223 patients needed to screen to find one HNRI). In
this group, there were no incidental findings on RUS unknown to the clinical team. In the
higher risk group, 15.7 percent had HN and 4.7 percent had HNRI. The NNS to find one case
of HN in the low risk group is 32, or $6,371 per positive study (at a cost of $200 per study).
For HNRI, the NNS for the low risk group in the same model was 223, at a cost of $44,600
per positive study. Conclusions: In adult in-patients with acute kidney injury, specific fac-Thesis award recipients 145
tors can identify patients who are unlikely to have hydronephrosis, or hydronephrosis re-
quiring an intervention, on renal ultrasound.
Functional Range of Motion of the Cervical and Lumbar Spine With and Without
Bracing. Christopher Perry Miller. Yale University School of Medicine, New Haven,
Connecticut.
Study Design: Biomechanical studies of the range of motion (ROM) of the spine in
asymptomatic subjects.
Objective: To define a normative data set for functional ROM of the cervical and lum-
bar spine and to evaluate how several common cervical and lumbar orthoses impact full, ac-
tive and functional ROM of the spine. 
Summary of Background Data: Spinal ROM is critical to normal function in daily tasks.
Previous studies have focused primarily on the maximum ROM of the spine (full, active ROM).
Functional ROM, the motion used while performing activities of daily living (ADLs), is typi-
cally much less than full, active ROM and may be a more clinically useful measure. However,
there have been few studies that have evaluated functional ROM in asymptomatic subjects or
in subjects wearing braces.
Methods: Electrogoniometers were attached to the subjects and used to continuously record
the full, active, and functional cervical and lumbar ROM of 60 asymptomatic subjects during 15
ADLs. Additionally, 10 additional subjects were selected to evaluate how two cervical orthoses
(a soft and rigid neck collar) and three lumbar orthoses (a soft corset, a semi-rigid off-the-shelf
lumbosacral orthosis [LSO], and a custom molded LSO) affected cervical and lumbar ROM.
Results: Normative lumbar and cervical functional ROM was significantly less than full,
active ROM. Cervical and lumbar orthoses demonstrate varying degrees of restriction of full,
active ROM. However, they are capable of restricting functional ROM at levels below what
is possible by physically restraining head motion, indicating that during ADLs spinal orthoses
act as proprioceptive aids to guide patients to restrict motion further than the mechanical con-
straint they provide.
Conclusions: These studies are some of the first to evaluate functional ROM in the
spine. The normative data provides a picture of how much spinal motion is needed during
ADLs. The bracing studies demonstrate how orthoses can act as proprioceptive aids to en-
courage the patient to self limit their own motion. It is possible that in certain, non-traumatic,
settings (such a post-operatively when internal fixation is generally utilized), less rigid
braces may be appropriately considered to minimize patient discomfort, increase wear com-
pliance, and decrease durable medical equipment costs.
Macrophage  Integrin-Mediated,  HuR-Dependent  Angiogenic  Factor  Gene 
Expression. Yasha Satish Modi. Yale University School of Medicine, New Haven,
Connecticut.
Activated macrophages, via the secretion of pro-angiogenic factors, modulate the an-
giogenic response to inflammation. Several of these factors, including vascular endothelial
growth factor (VEGF), are encoded by inherently unstable mRNA transcripts containing
AU-rich elements (AREs) in their 3’ untranslated region. During stress events, the half-
lives of these mRNAs must be prolonged to allow for significant protein production and an
adequate angiogenic response. This laboratory has demonstrated that engagement of the
ʲ2-integrin receptor, LFA-1, leads to stabilization of ARE-bearing mRNAs in T lymphocytes
through a nuclear-to-cytoplasmic translocation of the RNA-binding protein, HuR. Here, we
address whether ʲ2-integrin engagement stabilizes VEGF mRNA in macrophages in vitro
and at sites of angiogenesis via a HuR-dependent mechanism. To determine whether ʲ2-in-
tegrin engagement regulates VEGF mRNA stability, we adhered primary mouse bone mar-
row-derived macrophages to ICAM-1 (ʲ2-integrin ligand) for three hours. VEGF mRNA
degradation was measured by quantitative RT-PCR after transcriptional inhibition. In theThesis award recipients 146
cells bound to ICAM-1, the VEGF mRNA remained stable, whereas, in non-integrin en-
gaged control cells, VEGF mRNA degraded to less than 50 percent of initial levels within
60 minutes. Furthermore, in BMDMs deficient in HuR expression, VEGF mRNA from in-
tegrin-engaged cells degraded to 50 percent within 60 minutes, thus supporting the essen-
tial role of HuR in this stabilization event. To study inflammatory angiogenesis in vivo, we
used a subcutaneous polyvinyl alcohol (PVA) sponge model to assess differences in wild-
type and “macrophage-specific” conditional HuR knockout (HuRflox/floxLysM-Cre) mice.
Flow cytometry analyses of cells extracted from PVA sponges at one to four weeks showed
equal recruitment of F4/80+ cells in wild-type and HuR knockout mice. Immunofluores-
cence staining of excised PVA sponges confirmed equal macrophage recruitment and lo-
calization but revealed a reduction of VEGF production. Preliminary results indicate that
formation of CD31+ microvessels in HuR knockout mice is also decreased. We conclude
that macrophage ʲ2-integrin engagement results in stabilization of VEGF and that expres-
sion of HuR in macrophages is required for neovascular responses. These findings are rel-
evant to understanding the post-transcriptional regulatory mechanisms of inflammatory
angiogenesis.
Preterm Birth Results in Alterations in Neural Connectivity at Age 16 Years.
Katherine Marie Mullen. Yale University School of Medicine, New Haven, Connecticut.
Very low birth weight preterm (PT) children are at high risk for brain injury. This study
investigates microstructural differences in the brains of PT adolescents relative to term con-
trol subjects using diffusion tensor imaging (DTI), as well as studying their neurodevelop-
mental outcomes. Forty-four PT subjects (600 to 1,250 grams birth weight) without neonatal
brain injury and 41 term controls were evaluated at age 16 years with DTI, the Wechsler In-
telligence Scale for Children-III (WISC), the Peabody Picture Vocabulary Test-Revised
(PPVT), and the Comprehensive Test of Phonological Processing (CTOPP). PT subjects
scored lower than term subjects on WISC full scale (p = 0.002), verbal (p = 0.027), and
performance IQ tests (p = 0.001), as well as CTOPP phonological awareness (p = 0.005),
but scored comparably to term subjects on PPVT and CTOPP Rapid Naming tests. PT sub-
jects had lower fractional anisotropy (FA) values, suggestive of white matter disorganiza-
tion, in multiple regions, including bilateral uncinate fasciculi (left: p = 0.004; right: p =
0.002), bilateral external capsules (left: p < 0.0001; right: p = 0.001), the splenium of the
corpus callosum (p = 0.014), and white matter serving the inferior frontal gyrus bilaterally
(left: p < 0.0001; right: p = 0.005). FA values in both the left and right uncinate fasciculi cor-
related with PPVT scores (a semantic language task) in the PT subjects (left: R = 0.314, p
= 0.038; right: R = 0.336, p = 0.026). FA values in the left and right arcuate fasciculi cor-
related with CTOPP Rapid Naming scores (a phonologic task) in the PT subjects (left: R =
0.424, p = 0.004; right: R = 0.301, p = 0.047). For the first time, these data support the re-
cently proposed concept that dual pathways underlying language function are present in PT
adolescents. These include a left-sided dorsal pathway associated with phonological and
articulatory processing (arcuate fasciculus) and a bilateral ventral pathway for semantic,
receptive language processing (uncinate fasciculus). The striking bilateral dorsal correlations
for the PT group suggest that prematurely born subjects rely more heavily on the right hemi-
sphere than typically developing adolescents for performance of phonological language
tasks. These findings may represent either a delay in maturation or the engagement of al-
ternative neural pathways for language in the developing PT brain.
Extracellular Glutamate, Glutamine, and GABA in the Hippocampus and Cortex
of Refractory Epilepsy Patient. Jonathan Conrad Romanyshyn. Yale University
School of Medicine, New Haven, Connecticut.
Antiepileptic drug (AED) resistance affects one-third of patients with epilepsy and is
associated with significant disability. Brain microdialysis studies on the epileptogenic hip-Thesis award recipients 147
pocampus of patients with medication refractory epilepsy have identified elevations in ex-
tracellular glutamate, the primary brain excitatory neurotransmitter, both acutely during
seizures and chronically during the interictal periods. Whether extracellular glutamate, along
with  the  metabolites  glutamine  and  the  inhibitory  neurotransmitter  GABA  (gamma-
aminobutyric acid), are elevated in other cortical regions is unknown. In addition, the effect
of the administration of AEDs on the extracellular levels of these neurochemicals in pa-
tients with medication-refractory epilepsy is also unknown. Microdialysis samples were
obtained from probes coupled to the EEG depth electrodes and implanted in the cortex and
hippocampus of 81 awake patients with medication-refractory epilepsy undergoing in-
tracranial electroencephalographic (EEG) monitoring. Probes were classified according to
location and seizure activity into cortical or hippocampal non-epileptic, epileptogenic, prop-
agated, non-localized, or lesion sites. Samples were collected during the interictal period in
all subjects on their full AED dose during the first couple of days of their hospitalization and
then again (in a subset of 38 patients) after their AEDs were tapered. The samples were an-
alyzed with high performance liquid chromatography (HPLC) for glutamate, glutamine,
and GABA levels. Data were log-transformed and compared by ANOVA or multiple t-tests
with a Bonferroni correction, where appropriate. In the cortex, glutamate was significantly
higher in epileptogenic (mean ﾱ SEM, 17.3 ﾱ 5.1 ʼM), propagated (25.8 ﾱ 4.0 ʼM), non-
localized (43.9 ﾱ 9.9 ʼM), and lesion (46.9 ﾱ 9.0 ʼM) sites compared to non-epileptic cor-
tex  (2.6  ﾱ  0.3  ʼM).  In  the  hippocampus,  glutamate  was  significantly  higher  in  the
epileptogenic (10.3 ﾱ 1.9 ʼM) and propagated sites (33.0 ﾱ 13.8 ʼM) than non-epileptic
sites (2.8 ﾱ 0.5 ʼM). Glutamine was not significantly different between sites in both the
cortex and hippocampus. In the cortex, GABA was significantly elevated in propagated
(1503 ﾱ 273 nM) and lesion (827 ﾱ 183 nM) sites compared to non-epileptic sites (265 ﾱ
62 nM). In the hippocampus, GABA was elevated in the propagated (1079 ﾱ 395 nM) com-
pared to non-epileptic sites (391 ﾱ 169 nM). There were no significant differences in glu-
tamate, glutamine, or GABA between the hippocampus and cortex within non-epileptic,
epileptogenic, or propagated sites, which enabled cortical and hippocampal probes to be
combined. Glutamate was now found to be significantly elevated in propagated compared
to non-epileptic sites (p = 0.0001). GABA was significantly elevated in epileptogenic com-
pared to non-epileptic sites (p = 0.011) and in propagated compared to epileptogenic sites
(p = 0.028). After AED taper, there were no significant changes in glutamate in any site, al-
though it decreased non-significantly in non-localized sites (p = 0.090). Glutamine de-
creased  significantly  in  lesion  sites  (p  =  0.0095).  GABA  declined  significantly  in
non-localized sites (p = 0.014). When all sites were examined together, there were overall
significant decreases in glutamine (p = 0.0011) and GABA (p < 0.0001). In conclusion, el-
evations in glutamate and GABA extend beyond epileptogenic sites in patients with re-
fractory epilepsy. Levels of glutamate, glutamine, and GABA were comparable between
the hippocampus and cortex. AEDs may increase extracellular levels of glutamine and
GABA but are inefficient in reducing glutamate to normal levels in these patients, which
may relate to AED resistance.
A potential tolerogeneic role of skin grafts in previously tolerant animals.
Joshua Weiner, Kazuhiko Yamada, Joseph Scalea, Yoshinori Ishikawa, Masayoshi
Okumi, Adam Griesemer, Atsushi Hirakata, Justin Etter, Akira Shimizu, and David
H.  Sachs. Transplantation  Biology  Research  Center,  Massachusetts  General 
Hospital, Harvard Medical School, Boston, Massachusetts. (Sponsored by Sukru H.
Emre, Department of Surgery, Section of Transplantation and Immunology, Yale
University School of Medicine, New Haven, Connecticut.)
We have previously shown that long-term tolerance to class I disparate renal allografts
in miniature swine is induced by a short course of Cyclosporine A (CyA). In these tolerant
animals (TOL), the tolerance has been shown to involve T regulatory cells (Treg) and to per-
sist for three to four months after the graft is removed. Na￯ve animals can be sensitized toThesis award recipients 148
major histocompatibility complex (MHC) class I mismatched renal allografts by inocula-
tion with either class I peptide or by a donor-type skin graft. Six weeks after graftectomy,
peptide immunization similarly sensitized TOL swine, but challenge with donor skin failed
to sensitize (n = 3). In this study, we further investigated the tolerogenicity of skin grafts
under these conditions by challenging simultaneously with peptide and skin graft. Minia-
ture swine underwent bilateral nephrectomy and MHC class I mismatched renal transplan-
tation  with  a  12-day  course  of  CyA  to  induce  tolerance.  One  hundred  days  after
transplantation, graftectomy was performed and recipient-matched kidneys transplanted.
Six weeks later, pigs were simultaneously challenged with donor-type class I peptide and
donor-type skin grafts. The effect on in vitro and in vivo immunity was determined. In con-
trast to animals treated only with peptide, all of which were sensitized to second renal al-
lografts (rejection in four to six days) and developed strong anti-donor cellular and antibody
responses (n = 3), two of five recipients showed only a transient anti-donor cellular response
and no or little anti-donor antibody production and maintained their second donor-type class
I mismatched renal allografts long-term with normal creatinine. An additional animal ex-
perienced prolonged survival (11 days), and the final two animals rejected within five to
seven days. Challenging with second donor-type skin grafts and third party skin graft indi-
cated that hyporesponsiveness to the donor was specific. In animals tolerant of a class I
mismatched renal allograft, which would be expected to be sensitized by class I peptide
(indirect pathway of sensitization) at six weeks after graftectomy, a simultaneous donor-
matched skin graft appeared to prevent sensitization in two of five and prolong survival in
a third. These data are consistent with expansion of Treg following a class I mismatched skin
graft, presumably by the direct pathway of activation.